11740 Results

People

  1. Vickers
    Vickers
  2. Offit
    Offit
  3. Robson
    Robson
  4. Horwitz
    Horwitz
  5. Kingham
    Kingham
  6. Panageas
    Panageas
  7. Breitbart
    Breitbart
  8. Halpern
    Halpern
  9. Jarnagin
    Jarnagin
  10. Nelson
    Nelson

Groups

  1. Population Sciences Research Program (11740)
  2. Survivorship Research (5670)
  3. Department of Medicine (5134)
  4. Epidemiology and Biostatistics (4867)
  5. Solid Tumor Oncology Division (3333)
  6. Surgery (2965)
  7. Psychiatry and Behavioral Sciences, Department of (2780)
  8. Biostatistics Service (2339)
  9. GSK Faculty (2008)
  10. Health Outcomes Research Group (1948)
  1. "Population Sciences Research Program"
Formats
  1. Journal Article (7144)
  2. Meeting Abstract (3306)
  3. Book Section (330)
  4. Review (289)
  5. Editorial (253)
  6. Research Letter (116)
  7. Correspondence (111)
  8. Conference Paper (67)
  9. Guidelines (59)
  10. Miscellaneous (41)
  11. Book Whole (24)
Groups
  1. Population Sciences Research Program (11740)
  2. Survivorship Research (5670)
  3. Department of Medicine (5134)
  4. Epidemiology and Biostatistics (4867)
  5. Solid Tumor Oncology Division (3333)
  6. Surgery (2965)

More Groups

People
  1. Andrew Vickers (880)
  2. Kenneth Offit (788)
  3. Mark Robson (676)
  4. Steven Horwitz (645)
  5. T Peter Kingham (609)
  6. Katherine Panageas (512)

More People

Years
  1. 2025 (235)
  2. 2024 (722)
  3. 2023 (821)
  4. 2022 (828)
  5. 2021 (786)
  6. 2020 (738)

More Years

Publications
  1. Journal of Clinical Oncology (1246)
  2. Blood (374)
  3. Psycho-Oncology (347)
  4. Cancer (240)
  5. Cancer Research (234)
  6. Annals of Surgical Oncology (233)

More Publications

Publishers
  1. American Society of Clinical Oncology (1412)
  2. Elsevier Inc. (1128)
  3. Springer (1112)
  4. Elsevier Science, Inc. (816)
  5. Oxford University Press (753)
  6. Wiley Blackwell (614)

More Publishers

Results (11740)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Inherited mutations in breast cancer patients with and without multiple primary cancers
    Meeting Abstract

    Maxwell, K. N.; Vijai, J.; Lilyquist, J.; Slavin, T. P.; Kulkarni, A.; Vaccaro, O.; Wubbenhorst, B.; Neuhausen, S. L.; Hart, S.; Ravichandran, V.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Baseline demographics and disparities in cancer registration trials: An analysis of US Food and Drug Administration approved drugs in 2015 and 2016
    Meeting Abstract

    Maniar, R.; Green, A.; Bach, P.; Mailankody, S.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • The effect of acupuncture versus cognitive behavior therapy on insomnia in cancer survivors: A randomized clinical trial
    Meeting Abstract

    Mao, J. J.; Xie, S.; Duhamel, K.; Bao, T.; Kantoff, P. W.; Li, Q. S.; Barg, F.; Song, S.; Gehrman, P.; Garland, S. N.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • SAFE-HEaRt: A pilot study assessing the cardiac safety of HER2 targeted therapy in patients with HER2 positive breast cancer and reduced left ventricular function
    Meeting Abstract

    Lynce, F.; Barac, A.; Geng, X.; Dang, C. T.; Yu, A. F.; Smith, K. L.; Gallagher, C.; Pohlmann, P. R.; Nunes, R.; Herbolsheimer, P. M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A multi-histology basket trial of ado-trastuzumab emtansine in patients with HER2 amplified cancers
    Meeting Abstract

    Li, B. T.; Makker, V.; Buonocore, D. J.; Offin, M. D.; Olah, Z. T.; Panora, E.; Shen, R.; Ho, A. L.; Yaeger, R.; Iyer, G.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Detection of germline homologous recombination deficiency (HRD) in patients with metastatic esophagogastric (EG) cancer using clinical next generation sequencing (NGS)
    Meeting Abstract

    Janjigian, Y. Y.; Jonsson, P.; Kemel, Y.; Joseph, V.; Tuvy, Y.; Shameer, Z.; Ravichandran, V.; Zhang, L. Y.; Mandelker, D.; Ku, G. Y.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • The PRIMO study: A phase 2 study of duvelisib efficacy and safety in patients with relapsed or refractory peripheral t-cell lymphoma (PTCL)
    Meeting Abstract

    Horwitz, S. M.; Soto, J.; Youssoufian, H.; Lloyd, D.; Le, N. T.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Early response metrics for predicting trial outcomes: A report from volumetric CT for precision analysis of clinical trials (Vol-PACT)
    Meeting Abstract

    Hilden, P.; Gonen, M.; Connors, D. E.; Tang, Y.; Zhao, B.; Yang, H.; Karovic, S.; Flynn, J.; Adam, S.; Fojo, A. T.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Examining patients' medical and psychosocial experiences following detection of a CDH1 variant with multiplex genetic testing
    Meeting Abstract

    Hamilton, J.; Long, J. M.; Brandt, A. C.; Brower, J.; Symecko, H.; Salo-Mullen, E. E.; Christian, S.; Couch, F.; Garber, J. E.; Offit, K.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Ultra-low doses of TX-004HR to improve symptoms of vulvar and vaginal atrophy (VVA) while maintaining serum levels of estradiol within the normal postmenopausal range
    Meeting Abstract

    Goldfarb, S. B.; Carter, J.; Bernick, B.; Mirkin, S.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save